The EGFR family plays an essential role in normal organ development by mediating morphogenesis and differentiation through effects on cell proliferation, differentiation, apoptosis, invasion, and angiogenesis. Unlike normal cells that have tight regulatory mechanisms controlling EGFR pathways, tumor cells often have dysregulated EGFR signaling, allowing them to proliferate under adverse conditions, invade surrounding tissues, and increase angiogenesis. Epidermal growth factor receptor (EGFR) is a transmembrane receptor tyrosine kinase that belongs to the Human epidermal receptor (HER) family of receptors. Receptor protein tyrosine kinases play a key role in signal transduction pathways that regulate cell division and differentiation. Among the growth factor receptor kinases that have been identified as being important in cancer is epidermal growth factor receptor (EGFR) kinase (also known as erb-B1 or HER-1) and the related human epidermal growth factor receptor HER-2 (also known as erbB-2). The quinazoline and other heterocyclic skeletons are of great importance to chemists as well as biologists as it is available in a large variety of naturally occurring compounds. In this article we are emphasizing on various heterocycles such as Quinazoline, pyrrolotriazines etc. as promising anticancer agents. These heterocycles showed the anticancer activity through the inhibition of EGFR enzyme. Attempt will be taken to provide details information on the said topic in the benefit of medicinal chemist.
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Introduction
The quinazoline 1 Cancer chemotherapy has entered a new era of molecularly targeted therapeutics, which is highly selective and not associated with the serious toxicities of conventional cytotoxic drugs 15 .
The EGFR family plays an essential role in normal organ development by mediating morphogenesis and differentiation through effects on cell proliferation, differentiation, apoptosis, invasion, and angiogenesis 16, 17 . 
Figure1: EGFR pathway
This review is originated from the literature survey on the quinazoline and other important heterocyclic moiety [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] which shows the good EGFR/VEGFR inhibitory activity.
Quinazoline is the chemical entity that shows a very good promising anticancer activity through the EGFR inhibition, some moieties which are developed for good EGFR inhibitor activity are as follows.
Harold Mastalerz et al designed 14 compounds of Pyrrolotriazine dual EGFR/HER2
kinase inhibitors in that a 5-((4-aminopiperidin-1-yl) methyl) solubilizing group were found to be superior to analogs with previously reported C-5 solubilizing groups having IC 50 value 0.035. it has been shown in both pyrrolotriazine and quinazoline scaffolds to provide optimal dual EGFR and ErbB-2 kinase inhibitions. They were delighted to find that compound (11) displayed potent inhibition against both EGFR and ErbB-2 with IC 50 nM = 8 and 12, respectively, However, methyl substitution of the C-4 amino group abrogated both EGFR and ErbB-2 activities. Such a pronounced drop in activity against the enzyme suggested that C-4 NH 2 is necessary for binding, or that the methyl group prevents the molecule from attaining a proper conformation for binding to the enzyme. The benzamides 18 and the benzamidines (19) (20) small-molecules TKIs (tyrosine kinase inhibitors) that act by binding the intracellular portion of the receptor. In all the data above mentioned concludes that for the potential inhibition of the EGFR we need the heterocyclic rings e.g. quinazoline, pyrimidines are the most effectively used.
